Amundi

The expected end of the story

07/04/21 -"Amundi announced this morning that it has entered into exlcusive negotiations with Société Générale for the acquisition of Lyxor for a total cash consideration of €825m (€755m excluding excess ..."

PDF page sample
Pages
47
Language
English
Published on
07/04/21
Download
You may also be interested by these reports :
17/09/25
Bolloré published mixed H1 25 results following the deconsolidation of Vivendi. The group continued to buy back its shares at a good pace, thus ...
08/09/25
In our last teaser on Swissquote (SELL ; Switzerland), we explained how Swissquote’s naturally hedged business, backed by a growing and resilient ...
05/09/25
Since we last pushed Philips’ (Buy; Netherlands) investment case in January 2024, its share price performance has been glaringly ahead of the MedTech ...
04/09/25
D’Ieteren posted lacklustre H1 25 results, unsurprisingly burdened by a heavy interest charge, a complicated end market in auto retailer D’Ieteren ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO